EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
PROGRAMME AT A GlAnCE<br />
MOnDAy 24 JUnE <strong>2013</strong><br />
Poster session sunday 08:30 to Monday 18:00<br />
On behalf <strong>of</strong> the EsC Working Group on Cardiac Cellular Electrophysiology in the Poster Area<br />
14:00 - 18:00<br />
Moderated Posters: J-wave syndromes and arrhythmia complication after TAVI in the Moderated Poster Area<br />
Poster session 3 in the Poster Area<br />
12:45 - 13:45<br />
novel oral anticoagulants for stroke prevention .............................................Crete<br />
in atrial fibrillation: understanding our way forward<br />
Sponsored by Bristol Myers Squibb/Pfizer<br />
improved patient and economic outcomes with .......................................Rhodes<br />
advanced HF solutions - Sponsored by St. Jude Medical<br />
Reducing stroke risk: early AF detection and new ......................................Naxos<br />
anticoagulants - Sponsored by Medtronic<br />
left atrial appendage closure for risk reduction <strong>of</strong> ...............................Lefkada<br />
AF related stroke: what every electrophysiologist should know<br />
Sponsored by Boston Scientific<br />
Home Monitoring <strong>of</strong> cardiac devices: clinic efficiencies ....................Kythira<br />
and improved patient outcomes - Sponsored by BIOTRONIK<br />
Manage every lead - From implantation to extraction .........................Ithaca<br />
Sponsored by Spectranetics<br />
AF: a riddle wrapped in a mystery inside an enigma? .............Mykonos<br />
Sponsored by Bard Electrophysiology<br />
Fresh perspectives on hemodynamic ambulatory .......................Santorini<br />
optimization in CRT - Sponsored by Sorin Group<br />
Will percutaneous mitral valve repair impact ...............................................Hydra<br />
your management <strong>of</strong> patients with mitral regurgitation?<br />
Sponsored by Abbott Vascular<br />
14:00 - 15:30<br />
state <strong>of</strong> the art lecture: novel anticoagulants in atrial .....................Crete<br />
fibrillation<br />
Techno live session .................................................................................................................................Rhodes<br />
Honorary lectures .......................................................................................................................................Naxos<br />
Device and lead infections ..........................................................................................................Lefkada<br />
Managing cardiac resynchronisation therapy patients .................Kythira<br />
(Part ii) – The future is now!<br />
14:00 - 15:30 (continued)<br />
Gap junctions in myocardial disease ................................................................................Ithaca<br />
Translational session on brugada’s syndrome ....................................Mykonos<br />
Reduce iCD shocks: improve quality <strong>of</strong> life ..............................................Santorini<br />
Oral Abstract session: outcomes in CRT ............................................................Hydra<br />
15:30 - 16:30<br />
Working Group on Cardiac Cellular Electrophysiology ...........Ithaca<br />
General Assembly<br />
16:30 - 18:00<br />
State <strong>of</strong> the art lecture: atrial fibrillation ablation ..................................Crete<br />
in the Cath lab session .....................................................................................................................Rhodes<br />
Multimodality imaging <strong>of</strong> cardiac arrhythmias ...........................................Naxos<br />
Case session: lead extraction in challenging cases .....................Lefkada<br />
Pacing/ICDs/CRT:ECG/EGMs discussion (Part I).................................Kythira<br />
Calcium-store stability and arrhythmias ..................................................................Ithaca<br />
Gap junctions under cardiac ischaemia ..........................................................Mykonos<br />
Ablation <strong>of</strong> ventricular complex substrates..............................................Santorini<br />
Flash abstract presentations: cardiac resynchronisation...........Hydra<br />
therapy/Implantable cardioverter-defibrilator/Pacing<br />
18:15 - 19:15<br />
EPiC Advances: updated guidelines and clinical trials .....................Ithaca<br />
shaping the future <strong>of</strong> device and EP therapy<br />
Sponsored by EPIC Alliance<br />
18:15 - 19:45<br />
CRT Care Pathway: from patient selection to clinical ..................Naxos<br />
outcome - Sponsored by Medtronic<br />
status quo: antithrombotic management in atrial ........................................Kythira<br />
fibrillation - Sponsored by Bayer HealthCare<br />
TUESDAy 25 JUnE <strong>2013</strong><br />
08:30 - 12:30<br />
Moderated Posters: Hot topics in genetics and anticoagulation in the Moderated Poster Area<br />
Poster session 4 in the Poster Area<br />
08:30 - 10:00<br />
nightmares in electrophysiology: my worst case ever ..................Crete<br />
The new <strong>2013</strong> EsC Guidelines on pacing and cardiac .................Rhodes<br />
resynchronisation therapy<br />
Epicardial ventricular tachycardia ablation ......................................................Naxos<br />
The “unknowns“ in arrhythmogenic diseases .........................................Lefkada<br />
lead extraction, extension <strong>of</strong> the lead management .....................Kythira<br />
summit (Part i) indications for lead extraction<br />
Oral Abstract session: ablation: technical aspects................................Ithaca<br />
Worldwide debatable topics ..............................................................................................Mykonos<br />
Catheter ablation <strong>of</strong> outflow tract ventricular ...................................Santorini<br />
tachycardia<br />
Oral Abstract session: translational view on atrial .............................Hydra<br />
fibrillation<br />
11:00 - 12:30<br />
late breaking Trial session i .......................................................................................................Crete<br />
Techno live session ....................................................................................................................................Rhodes<br />
Ablation <strong>of</strong> idiopathic ventricular tachycardias and ...........................Naxos<br />
premature ventricular complexes<br />
Debated issues in channelopathies.............................................................................Lefkada<br />
lead extraction, extension <strong>of</strong> the lead management .....................Kythira<br />
summit (Part ii) state <strong>of</strong> the art in lead extraction techniques<br />
Oral Abstract Session: atrial fibrillation: Clinical Aspects .......Ithaca<br />
How to solve clinical problems in pacemakers patients .....Mykonos<br />
Catheter ablation <strong>of</strong> longstanding persistent atrial .....................Santorini<br />
fibrillation<br />
Oral Abstract session: translational view on ventricular.........Hydra<br />
electrophysiology<br />
9
Change language